CLS
Celestica Inc.
CLS's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over CLS overall, supported by stronger valuation and stronger fundamentals.
CLS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
CLS's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $115 | -55% |
| Forward | 14x | $254 | — |
| Fair | 17x | $184 | -28% |
| Current | 24x | $254 | — |
| Expensive | 39x | $411 | +62% |
Historical ranges are pointers, not guarantees.
CLS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over CLS in the historical PE scenario, which offers more potential upside but is not a forecast.
CLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for CLS, with profitability holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over CLS on the outlook, with more favorable profitability expectations.
CLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $17.88 | +70% |
| Q3 2026 | $10.55 | +75% |
| Q2 2026 | $9.60 | +114% |
| Q1 2026 | $8.25 | +138% |
| Q4 2025 | $7.16 | +105% |
| Q3 2025 | $6.03 | +98% |
| Q2 2025 | $4.49 | +53% |
| Q1 2025 | $3.47 | +33% |
| Q4 2024 | $3.50 | +72% |
CLS's earnings per share have climbed steadily: $10.55 over the past year, up 75% from the year before, and higher year over year for 23 quarters in a row.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
CLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.8B | +83% |
| Q2 2026 | $4.7B | +62% |
| Q1 2026 | $4B | +53% |
| Q4 2025 | $3.7B | +44% |
| Q3 2025 | $3.2B | +28% |
| Q2 2025 | $2.9B | +21% |
| Q1 2025 | $2.6B | +20% |
| Q4 2024 | $2.5B | +19% |
CLS's revenue has grown year over year for 20 quarters in a row: $5.8B last quarter, up 83% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -2.3 points |
| Q2 2026 | 9.8% | +0.3 points |
| Q1 2026 | 6.7% | +1.9 points |
| Q4 2025 | 8.6% | +0.9 points |
| Q3 2025 | 10% | +4.7 points |
| Q2 2025 | 9.4% | +3.9 points |
| Q1 2025 | 4.9% | -0.8 points |
| Q4 2024 | 7.7% | +2.1 points |
CLS's operating margin was 7.9% last quarter, down 2.3 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CLS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CLS on profitability, with a higher operating margin.
CLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $115.6M | +30% |
| Q2 2026 | $147.1M | +23% |
| Q1 2026 | $126.8M | +35% |
| Q4 2025 | $155.9M | +471% |
| Q3 2025 | $88.9M | -10% |
| Q2 2025 | $119.9M | +91% |
| Q1 2025 | $93.6M | +38% |
| Q4 2024 | $27.3M | -74% |
CLS's free cash flow has been positive every quarter for seven years: $545M over the past year, up 65% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CLS on cash flow, with more consistent year-over-year improvement.
CLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +5.6M shares |
| 1 year | +5.1% | +5.9M shares |
| 3 years | +1.8% | +2.2M shares |
| 5 years | -2.9% | -3.7M shares |
| Available history | -5.2% | -6.7M shares |
CLS has 122M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $22.6M |
| Q4 2025 | $35.7M |
| Q3 2025 | — |
| Q2 2025 | $40M |
| Q1 2025 | $77.7M |
| Q4 2024 | $25.5M |
CLS spent $58M buying back its own shares over the past year, down 59% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over CLS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
CLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.5x | Very low |
CLS has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 15.5 | Oversold |
CLS's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CLS PE vs Technology Sector
| Metric | CLS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 14% below |
| PE % | 64 | 35 | 29 pts above |
CLS is trading at 24x earnings, a 14% discount to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over CLS on valuation relative to its sector.
CLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $300.6 | 15% below |
| 20 week MA | $313.9 | 19% below |
| 50 week MA | $321.3 | 21% below |
| 100 week MA | $243.1 | 4.5% above |
| 200 week MA | $139.6 | 82% above |
CLS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 82% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over CLS on trend strength, trading above more of its moving averages.
CLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $7.71 | -4.9% |
| 2021 | $7.71 | $10.9 | +41% |
| 2022 | $10.9 | $10.9 | -0.2% |
| 2023 | $10.9 | $29.3 | +170% |
| 2024 | $29.3 | $95.1 | +225% |
| 2025 | $95.1 | $303.6 | +219% |
| 2026 YTD | $303.6 | $254.0 | -16% |
CLS has finished higher in four of the last six years, three of them by more than 50%. It's down 16% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CLS on returns for 2026, with the stronger performance.